Efficacy of three innovative bacterin vaccines against experimental infection with mycoplasma hyopneumoniae

HIGHLIGHTS

  • who: Anneleen Marguerite Filip Matthijs from the (UNIVERSITY) have published the research work: Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae, in the Journal: (JOURNAL)
  • what: The aim of this experi‑ mental study was to assess the efficacy of three experimental bacterin formulations based on M. hyopneumoniae field strain F7.2C which were able to induce cellular immunity. This study demonstrated the potential of innovative M. hyopneumoniae bacterin formulations and identified promising vaccine candidates for further exploration. In the present study, groups Lipo_DDA:TDB and SWE_TLR had significantly more M. hyopneumoniae . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?